News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,774 Results
Type
Article (49016)
Company Profile (288)
Press Release (668470)
Section
Business (211790)
Career Advice (2070)
Deals (36469)
Drug Delivery (88)
Drug Development (83283)
Employer Resources (168)
FDA (16844)
Job Trends (15652)
News (358108)
Policy (34579)
Tag
Academia (2757)
Africa (788)
Alliances (51180)
Alzheimer's disease (1208)
Approvals (16771)
Arizona (186)
Artificial intelligence (97)
Asia (40010)
Australia (6576)
Bankruptcy (363)
Best Places to Work (11807)
Biotechnology (200)
Breast cancer (79)
C2C Services and Suppliers (86222)
California (2152)
Canada (1019)
Cancer (651)
Career advice (1734)
Cell therapy (153)
China (168)
Clinical research (65360)
Collaboration (202)
Colorado (92)
Compensation (113)
Connecticut (96)
COVID-19 (2623)
Cystic fibrosis (78)
Data (481)
Diabetes (101)
Diagnostics (6216)
Drug pricing (79)
Earnings (85806)
Employer resources (143)
Europe (86427)
Events (113000)
Executive appointments (192)
FDA (17158)
Florida (311)
Funding (191)
Gene therapy (109)
Georgia (75)
GLP-1 (572)
Government (4576)
Healthcare (19696)
Hotbed/Location (497383)
Illinois (300)
Indiana (158)
Infectious disease (2666)
Inflammatory bowel disease (98)
Interviews (314)
IPO (16583)
Job creations (4035)
Job search strategy (1492)
Kansas (97)
Layoffs (418)
Legal (8389)
Lung cancer (128)
Manufacturing (115)
Maryland (461)
Massachusetts (1784)
Medical device (14061)
Medtech (14066)
Mergers & acquisitions (19797)
Metabolic disorders (311)
Michigan (135)
Minnesota (235)
Neuroscience (1399)
New Jersey (663)
New York (674)
NextGen Class of 2024 (6881)
Non-profit (4716)
North Carolina (664)
Northern California (936)
Obesity (192)
Ohio (115)
Opinion (186)
Patents (80)
Pennsylvania (635)
People (58770)
Phase I (20233)
Phase II (28713)
Phase III (21519)
Pipeline (141)
Postmarket research (2729)
Preclinical (8624)
Press Release (67)
Radiopharmaceuticals (240)
Rare diseases (155)
Real estate (6281)
Regulatory (22690)
Research institute (2467)
Resumes & cover letters (357)
South America (1179)
Southern California (868)
Startups (3815)
Texas (284)
United States (9754)
Vaccines (528)
Washington State (274)
Weight loss (160)
Date
Last 7 days (670)
Last 30 days (2583)
Last 365 days (37523)
2024 (28202)
2023 (41144)
2022 (52382)
2021 (57104)
2020 (55917)
2019 (48803)
2018 (36941)
2017 (33762)
2016 (33573)
2015 (39619)
2014 (33333)
2013 (28568)
2012 (30850)
2011 (31563)
2010 (29925)
717,774 Results for "medical marijuana inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance
MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) (“MIRA” or the “Company”), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and neuropsychiatric disorders, announced that MIRA-55, has been determined by the U.S. Drug Enforcement Administration (DEA) not to be a controlled substance or listed chemical under the Controlled Substance Act and its governing regulations.
May 29, 2024
·
6 min read
Business
Avanos Medical, Inc. Appoints Indrani Franchini to Board of Directors
Avanos Medical, Inc. (NYSE: AVNS) today announced that Indrani Franchini has been appointed as a new independent member of the Avanos board of directors.
July 1, 2024
·
2 min read
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million.
July 1, 2024
·
18 min read
Business
GT Medical Technologies, Inc. Appoints Two Industry Medical Device Veterans to Key Leadership Positions
GT Medical Technologies, Inc. today announced two significant additions to its leadership team: Tom Moore as Chief Commercial Officer and Sandeep Yadav as Chief Financial Officer.
June 20, 2024
·
2 min read
Deals
Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Silk Road Medical, Inc.
June 18, 2024
·
7 min read
Inc. Magazine Names Xenco Medical one of the Best Companies to Work for in America
Inc. Magazine has named trailblazing life sciences company Xenco Medical one of the best companies to work for in America.
June 18, 2024
·
2 min read
Business
Mindset Medical, Inc Raises Funds to Continue Development and Clinical Trials for Informed Vital Core
Mindset Medical, Inc., a software as a medical device company, has announced the closing of a Series A financing.
June 6, 2024
·
3 min read
Business
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
Spectral Medical Inc., a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, announced the results of its Annual Meeting of shareholders.
June 7, 2024
·
3 min read
BioMidwest
Inspire Medical Systems, Inc. to Present at the Truist Securities Medtech Conference
Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Truist Securities Medtech Conference on Tuesday, June 18, 2024.
June 4, 2024
·
1 min read
Business
Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its financial results for the quarter ending September 30, 2022, and provided an overview of recent operational highlights.
November 22, 2022
·
3 min read
1 of 71,778
Next